D. Parsons

发表

An Integrated Genomic Analysis of Human Glioblastoma Multiforme

D. Busam, R. Strausberg, G. Parmigiani, 2008, Science.

Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses

G. Parmigiani, K. Kinzler, B. Vogelstein, 2008, Science.

The Genomic Landscapes of Human Breast and Colorectal Cancers

A. Sparks, G. Parmigiani, J. Ptak, 2007, Science.

Integrated analysis of homozygous deletions, focal amplifications, and sequence alterations in breast and colorectal cancers

G. Parmigiani, L. Wood, K. Kinzler, 2008, Proceedings of the National Academy of Sciences.

The Consensus Coding Sequences of Human Breast and Colorectal Cancers

G. Parmigiani, J. Ptak, L. Wood, 2006, Science.

Responsibility, culpability, and parental views on genomic testing for seriously ill children

D. Parsons, A. McGuire, S. Plon, 2019, Genetics in Medicine.

IDH1 and IDH2 mutations in gliomas.

R. McLendon, A. Friedman, B. Vogelstein, 2009, The New England journal of medicine.

Mutational Analysis of the Tyrosine Kinome in Colorectal Cancers

G. Parmigiani, J. Ptak, K. Kinzler, 2003, Science.

A multidimensional analysis of genes mutated in breast and colorectal cancers.

G. Parmigiani, L. Wood, K. Kinzler, 2007, Genome research.

The Genetic Landscape of the Childhood Cancer Medulloblastoma

Zev A. Binder, G. Parmigiani, M. Berger, 2011, Science.

Colorectal cancer: Mutations in a signalling pathway

J. Ptak, K. Kinzler, B. Vogelstein, 2005, Nature.

Germline Findings in Tumor-Only Sequencing: Points to Consider for Clinicians and Laboratories.

A. Chinnaiyan, D. Parsons, S. Plon, 2016, Journal of the National Cancer Institute.

Clinical Sequencing Exploratory Research Consortium: Accelerating Evidence-Based Practice of Genomic Medicine.

Nikhil Wagle, Peter Tarczy-Hornoch, Richard M Myers, 2016, American journal of human genetics.

Diagnostic Yield of Clinical Tumor and Germline Whole-Exome Sequencing for Children With Solid Tumors.

Tao Wang, Katie Bergstrom, Amy L McGuire, 2016, JAMA oncology.

Germline POLE mutation in a child with hypermutated medulloblastoma and features of constitutional mismatch repair deficiency

D. Parsons, S. Plon, Angshumoy Roy, 2019, Cold Spring Harbor molecular case studies.

Molecular subgroups of medulloblastoma: the current consensus

Scott L. Pomeroy, Stefan M. Pfister, Paul A. Northcott, 2011, Acta Neuropathologica.

Reliable tumor detection by whole-genome methylation sequencing of cell-free DNA in cerebrospinal fluid of pediatric medulloblastoma

D. Parsons, Xiao-Nan Li, Deqiang Sun, 2020, Science Advances.

Exomic Sequencing Identifies PALB2 as a Pancreatic Cancer Susceptibility Gene

Alison P. Klein, James R. Eshleman, Giovanni Parmigiani, 2009, Science.

A Validation Framework for Somatic Copy Number Detection in Targeted Sequencing Panels.

D. Parsons, S. Plon, Angshumoy Roy, 2022, The Journal of molecular diagnostics : JMD.

Intragenic telSMN mutations: frequency, distribution, evidence of a founder effect, and modification of the spinal muscular atrophy phenotype by cenSMN copy number.

D. Parsons, J. Mendell, S. Iannaccone, 1998, American journal of human genetics.

Precision medicine in pediatric oncology: Lessons learned and next steps

A. Chinnaiyan, D. Parsons, J. Prensner, 2017, Pediatric blood & cancer.

Alternative genetic mechanisms of BRAF activation in Langerhans cell histiocytosis.

D. Wheeler, D. Parsons, N. Kakkar, 2016, Blood.

Inferring clonal composition from multiple tumor biopsies

Mar'ia Rodr'iguez Mart'inez, D. Parsons, Pavel Sumazin, 2017, npj Systems Biology and Applications.

From One to Many: Further Refinement of Medulloblastoma Subtypes Offers Promise for Personalized Therapy.

D. Parsons, A. Bavle, D. W. Parsons, 2017, Cancer cell.

Xenotransplantation of pediatric low grade gliomas confirms the enrichment of BRAF V600E mutation and preservation of CDKN2A deletion in a novel orthotopic xenograft mouse model of progressive pleomorphic xanthoastrocytoma

D. Parsons, J. Murray, C. Lau, 2017, Oncotarget.

Integrated DNA and RNA sequencing reveals targetable alterations in metastatic pediatric papillary thyroid carcinoma

D. Parsons, N. Kakkar, Angshumoy Roy, 2020, Pediatric blood & cancer.

Actionable Tumor Alterations and Treatment Protocol Enrollment of Pediatric and Young Adult Patients With Refractory Cancers in the National Cancer Institute–Children's Oncology Group Pediatric MATCH Trial

D. Parsons, N. Ramirez, T. Alonzo, 2022, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

ZFTA-RELA Dictates Oncogenic Transcriptional Programs to Drive Aggressive Supratentorial Ependymoma.

D. Parsons, S. Pfister, Baoli Hu, 2021, Cancer discovery.

Durable Response to Larotrectinib in a Child With Histologic Diagnosis of Recurrent Disseminated Ependymoma Discovered to Harbor an NTRK2 Fusion: The Impact of Integrated Genomic Profiling.

R. Gibbs, D. Muzny, D. Parsons, 2021, JCO precision oncology.

Novel patient-derived xenograft and cell line models for therapeutic testing of pediatric liver cancer.

G. Mills, D. Muzny, D. Parsons, 2016, Journal of hepatology.

Integrated tumor and germline whole-exome sequencing identifies mutations in MAPK and PI3K pathway genes in an adolescent with rosette-forming glioneuronal tumor of the fourth ventricle

D. Wheeler, D. Parsons, R. Person, 2016, Cold Spring Harbor molecular case studies.

Somatic Mutations in the Chromatin Remodeling Gene ARID1A Occur in Several Tumor Types

Meng Li, Christine A Iacobuzio-Donahue, Bert Vogelstein, 2011, Human mutation.

Fixing the leaky pipeline: identifying solutions for improving pediatrician-scientist training during pediatric residency

D. Parsons, R. Blankenburg, J. Orange, 2020, Pediatric Research.

When Participants in Genomic Research Grow Up: Contact and Consent at the Age of Majority.

Melissa A. Basford, John A. Lynch, Terrie E. Kitchner, 2016, The Journal of pediatrics.

SMAD4 Gene Mutations Are Associated with Poor Prognosis in Pancreatic Cancer

Giovanni Parmigiani, Amanda Blackford, Christine A Iacobuzio-Donahue, 2009, Clinical Cancer Research.

50 Years Ago in The Journal of Pediatrics: Adrenocortical Neoplasms with Hemihypertrophy, Brain Tumors, and Other Disorders.

D. Parsons, S. Plon, Emily B. Heikamp, 2017, The Journal of pediatrics.

An 11 base pair duplication in exon 6 of the SMN gene produces a type I spinal muscular atrophy (SMA) phenotype: further evidence for SMN as the primary SMA-determining gene.

D. Parsons, J. Mendell, U. Monani, 1996, Human molecular genetics.

Clinical and molecular features of pediatric cancer patients with Lynch syndrome

R. Gibbs, D. Muzny, D. Parsons, 2021, Pediatric blood & cancer.

Erratum: Clinical Sequencing Exploratory Research Consortium: Accelerating Evidence-Based Practice of Genomic Medicine (American Journal of Human Genetics (2016) 98(6) (1067–1076) (S0002929716301069) (10.1016/j.ajhg.2016.04.011))

Sara Chandros Hull, Robert C. Green, Sean D. Mooney, 2016 .

Mutations of IDH1 and IDH2 are not detected in brain metastases of colorectal cancer

D. Parsons, L. Diaz, M. Holdhoff, 2009, Journal of Neuro-Oncology.

Pediatric Oncologists’ Experiences Returning and Incorporating Genomic Sequencing Results into Cancer Care

D. Parsons, A. McGuire, R. Street, 2021, Journal of personalized medicine.

A single nucleotide difference that alters splicing patterns distinguishes the SMA gene SMN1 from the copy gene SMN2.

J. McPherson, D. Parsons, C. Lorson, 1999, Human molecular genetics.

Activating MAPK1 (ERK2) mutation in an aggressive case of disseminated juvenile xanthogranuloma

D. Wheeler, D. Parsons, M. Merad, 2017, Oncotarget.

Mutations of PTCH1, MLL2, and MLL3 are not frequent events in hepatoblastoma

D. Parsons, Angshumoy Roy, M. Chintagumpala, 2012, Pediatric blood & cancer.